Tekla Life Sciences Inves... (HQL)

12.50

0.02 (0.16%)

At close: Apr 28, 2025, 3:59 PM

12.51

0.08%

After-hours: Apr 28, 2025, 04:05 PM EDT

Tekla Life Sciences Investors Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Revenue	86.69M	23.52M	-103.25M	65.69M	124.08M	2.44M	1.99M	69.81M	6.29M
Cost of Revenue	n/a	5.24M	5.55M	6.08M	5.21M	n/a	n/a	4.61M	4.95M
Gross Profit	86.69M	18.28M	-108.8M	59.61M	118.88M	2.44M	1.99M	65.2M	1.34M
Operating Income	85.3M	-5.24M	-104.6M	64.53M	123.05M	-2.88M	-3.61M	-3.88M	-3.79M
Interest Income	1.04M	204.45K	50.09K	n/a	164.8K	n/a	n/a	90.56K	n/a
Pretax Income	85.3M	22.35M	-104.6M	64.53M	123.05M	-70.48M	28.66M	68.56M	-11.91M
Net Income	85.3M	22.35M	-104.6M	64.53M	123.05M	-70.48M	28.66M	68.56M	-11.91M
Selling & General & Admin	1.33M	903.14K	1.08M	844.02K	751.32K	5.32M	5.59M	991.51K	-1.89
Research & Development	n/a	n/a	-3.28	1.43	3.15	n/a	n/a	1.46	-1.89
Other Expenses	n/a	22.62M	275.97K	313.69K	278.66K	n/a	n/a	423.33K	20.74M
Operating Expenses	1.39M	23.52M	1.35M	1.16M	1.03M	5.32M	5.59M	1.26M	13.35M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	72.43M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.39M	23.52M	1.35M	1.16M	1.03M	5.32M	5.59M	5.56M	1.34M
Income Tax Expense	n/a	n/a	-2.99M	-4.15M	-2.13M	n/a	n/a	3.00	26.32M
Shares Outstanding (Basic)	n/a	28.29M	25.68M	24.26M	23.85M	23.18M	22.41M	21.36M	-11.91M
Shares Outstanding (Diluted)	28.06M	28.29M	25.68M	24.26M	23.85M	23.18M	22.41M	21.36M	-0.57
EPS (Basic)	n/a	0.79	-4.07	2.66	5.16	-3.04	1.28	3.21	1.00
EPS (Diluted)	3.04	0.79	-4.07	2.66	5.16	-3.04	1.28	3.21	20.74M
EBITDA	n/a	22.35M	-104.61M	64.54M	123.06M	n/a	n/a	68.56M	n/a
EBIT	n/a	22.35M	-104.61M	64.54M	123.06M	-2.88M	-3.61M	-3.88M	-3.79M
Depreciation & Amortization	n/a	27.6M	2.99M	4.14M	2.11M	2.88M	3.61M	3.88M	3.79M